# Frank Misselwitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/frank-misselwitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,613 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 46 |
| i10-index | 84 |
| Last Known Institution | Cytel (United States) |
| OpenAlex ID | https://openalex.org/A5088406700 |
| ORCID iD | https://orcid.org/0000-0003-1366-7958 |
| Works | 168 |

## Researcher papers

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Developing Therapies for Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/developing-therapies-for-heart-failure-with-preserved-ejection-fraction/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Cytel (United States)](https://scholariq.org/institutions/cytel-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
